02nd week of 2016 patent applcation highlights part 9 |
Patent application number | Title | Published |
20160008331 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE | 2016-01-14 |
20160008332 | COMBINATORIAL COMPOSITIONS AND METHODS FOR TREATMENT OF MELANOMA | 2016-01-14 |
20160008333 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR POSTERIOR OCULAR DISEASE CONTAINING TETRAHYDROPYRANYLAMINOCYCLOPENTYLCARBONYLTETRAHYDROPYRIDOPYRIDINE DERIVATIVE AS EFFECTIVE INGREDIENT | 2016-01-14 |
20160008334 | Preparations for the Treatment of Sleep-Related Respiratory Disorders | 2016-01-14 |
20160008335 | PHARMACEUTICAL COMPOSITIONS OF DONEPEZIL HAVING SPECIFIC IN VITRO DISSOLUTION PROFILE OR PHARMACOKINETICS PARAMETERS | 2016-01-14 |
20160008336 | HDAC INHIBITORS FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY | 2016-01-14 |
20160008337 | Compositions and Methods for the Treatment of Presbyopia | 2016-01-14 |
20160008338 | DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS | 2016-01-14 |
20160008339 | PSORALEN DERIVATIVES FOR PREVENTING OR TREATING HEART FAILURE OR CARDIAC HYPERTROPHY | 2016-01-14 |
20160008340 | PHARMACEUTICAL COMPOSITION INCLUDING MIGRATORY FACTOR FOR GUIDING PLURIPOTENT STEM CELLS TO INJURY | 2016-01-14 |
20160008341 | CRYSTALLINE N-[5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINY- L)PHENYL]ACETAMIDE MONO MESYLATE MONOHYDRATE HAVING A SPECIFIC PARTICLE SIZE DISTRIBUTION RANGE AND A SPECIFIC SURFACE AREA RANGE FOR USE IN PHARMACEUTICAL FORMULATIONS | 2016-01-14 |
20160008342 | METHODS OF IMPROVING CELL-BASED THERAPY | 2016-01-14 |
20160008343 | COMPOUNDS AND METHODS OF PROPHYLAXIS AND TREATMENT REGARDING NICOTINIC RECEPTOR ANTAGONISTS | 2016-01-14 |
20160008344 | METHODS FOR THE TREATMENT OF NON-HODGKIN'S LYMPHOMAS USING LENALIDOMIDE, AND GENE AND PROTEIN BIOMARKERS AS A PREDICTOR | 2016-01-14 |
20160008345 | METHODS FOR TREATING GLIOMAS WITH 4-(AMINO)-2-(2,6-DIOXO(3-PIPERIDYL))-ISOINDOLINE-1,3-DIONE | 2016-01-14 |
20160008347 | THERAPEUTIC USES OF NICOTINE | 2016-01-14 |
20160008348 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR MILD COGNITIVE IMPAIRMENT | 2016-01-14 |
20160008349 | SUBLINGUAL NALOXONE SPRAY | 2016-01-14 |
20160008352 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2016-01-14 |
20160008353 | PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSION, ANXIETY, AND NEURODEGENERATIVE DISORDERS | 2016-01-14 |
20160008354 | SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR PREVENTING RETINAL DYSFUNCTION | 2016-01-14 |
20160008355 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ERYTHEMA | 2016-01-14 |
20160008356 | TREATMENT OF CANCER WITH TOR KINASE INHIBITORS | 2016-01-14 |
20160008357 | PYRIDAZINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING COGNITIVE IMPAIRMENT | 2016-01-14 |
20160008358 | STABLE PHARMACEUTICAL INJECTABLE COMPOSITIONS OF VORICONAZOLE | 2016-01-14 |
20160008359 | AZAINDOLES USEFUL AS INHIBITORS OF JANUS KINASES | 2016-01-14 |
20160008360 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH THE 5-HT1A AND 5-HT2A RECEPTORS | 2016-01-14 |
20160008361 | COMPOSITIONS AND METHODS FOR TREATING CANCER | 2016-01-14 |
20160008362 | AGENT FOR PREVENTING AND/OR TREATING OCULAR INFLAMMATORY DISEASE | 2016-01-14 |
20160008363 | DRUG COMBINATION | 2016-01-14 |
20160008364 | METHODS FOR TREATING NEUROLOGIC DISORDERS | 2016-01-14 |
20160008365 | METHODS OF TREATING A CANCER USING SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF | 2016-01-14 |
20160008366 | BTK INHIBITORS FOR THE TREATMENT OF CNS MALIGNANCIES | 2016-01-14 |
20160008367 | Combination Comprising a Cyclin Dependent Kinase 4 or Cyclin Dependent Kinase (CDK4/6) Inhibitor for Treating Cancer | 2016-01-14 |
20160008368 | Combination | 2016-01-14 |
20160008369 | ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG | 2016-01-14 |
20160008370 | LOCAL TOPICAL ADMINISTRATION FORMULATIONS CONTAINING INDOXACARB | 2016-01-14 |
20160008371 | FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA | 2016-01-14 |
20160008372 | METHODS AND COMPOSITIONS FOR TREATING MIGRAINES USING NORIBOGAINE | 2016-01-14 |
20160008373 | NUTRITIONAL AND MEDICINAL ORAL COMPOSITION FOR VETERINARY USE | 2016-01-14 |
20160008374 | MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV | 2016-01-14 |
20160008375 | PHARMACEUTICAL FORMULATIONS COMPRISING QUETIAPINE AND ESCITALOPRAM | 2016-01-14 |
20160008376 | Compositions, Methods and Uses for Treating Gender-Biased Immune Disorders | 2016-01-14 |
20160008377 | FORMULATIONS AND COMPOSITIONS OF VITAMIN D ANALOGS FOR TREATING AND PREVENTING CANCER AND OTHER DISEASES | 2016-01-14 |
20160008378 | METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS BY STIMULATING ER STRESS | 2016-01-14 |
20160008379 | PHARMACEUTICAL COMPOSITION OF DOXYCYCLINE WITH REDUCED FOOD EFFECT | 2016-01-14 |
20160008380 | TARGETING GLUTAMINE METABOLISM IN BRAIN TUMORS | 2016-01-14 |
20160008381 | Combined Treatment Utilizing VB-201 | 2016-01-14 |
20160008382 | METHODS OF TREATMENT OF CANCER | 2016-01-14 |
20160008383 | Dosing Regimens for Treating And/Or Preventing Cerebral Amyloidoses | 2016-01-14 |
20160008384 | PREBIOTIC FORMULATIONS AND METHODS OF USE | 2016-01-14 |
20160008385 | ADRENOMEDULLIN PRODUCTION ENHANCER | 2016-01-14 |
20160008386 | COMPOSITION AND METHOD FOR INDUCING EPO-MEDIATED HAEMOGLOBIN EXPRESSION AND MITOCHONDRIAL BIOGENESIS IN NONHAEMATOPOIETIC CELL | 2016-01-14 |
20160008387 | AGENTS AND DEVICES FOR AFFECTING NERVE FUNCTION | 2016-01-14 |
20160008388 | COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | 2016-01-14 |
20160008389 | Cell-Penetrating Oligonucleotides | 2016-01-14 |
20160008390 | METHODS OF TREATING CANCER | 2016-01-14 |
20160008391 | GALACTOSAMINOGALACTAN COMPRISING alpha-1-4 LINKED GALACTOSE AND alpha-1-4 LINKED N-ACETYLGALACTOSAMINE FOR USE IN THE TREATMENT OF AT LEAST ONE INFLAMMATORY DISEASE | 2016-01-14 |
20160008392 | AGENT FOR LIFESTYLE-RELATED DISEASE AND ORAL COMPOSITION COMPRISING SAME | 2016-01-14 |
20160008393 | METHODS FOR THE TREATMENT OF HEPATITIS B AND HEPATITIS D VIRUS INFECTIONS | 2016-01-14 |
20160008394 | INORGANIC NITRITE TO IMPROVE CARDIOPULMONARY HEMODYNAMICS | 2016-01-14 |
20160008395 | Process For The Preparation Of A Non-Corrosive Base Solution And Methods Of Using Same | 2016-01-14 |
20160008396 | RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME | 2016-01-14 |
20160008397 | IMMUNOMODULATION BY CONTROLLING EXPRESSION LEVELS OF MICRORNAS IN DENDRITIC CELLS | 2016-01-14 |
20160008398 | CONSTITUTIVE EXPRESSION OF COSTIMULATORY LIGANDS ON ADOPTIVELY TRANSFERRED T LYMPHOCYTES | 2016-01-14 |
20160008399 | COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE | 2016-01-14 |
20160008400 | METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD | 2016-01-14 |
20160008401 | PROTECTION OF THE VASCULAR ENDOTHELIUM FROM IMMUNOLOGICALLY MEDIATED CYTOTOXIC REACTIONS WITH HUMAN CD34-NEGATIVE PROGENITOR CELLS | 2016-01-14 |
20160008402 | ADIPOSE TISSUE-DERIVED STEM CELLS FOR VETERINARY USE | 2016-01-14 |
20160008403 | Transplantation of Neural Cells | 2016-01-14 |
20160008404 | POSTNATAL STEM CELLS AND USES THEREOF | 2016-01-14 |
20160008405 | METHOD OF TREATMENT FOR PULPITIS AND/OR ENHANCEMENT FOR DENTINOGENESIS | 2016-01-14 |
20160008406 | Traditional Chinese medicine complex composite for significantly improving high density lipoprotein concentration in serum and preparation method thereof | 2016-01-14 |
20160008407 | TISSUE PROCESSING APPARATUS WITH FLUID SUCTION FEATURES AND METHODS RELATING TO COLLECTING AND PROCESSING HUMAN BIOLOGICAL MATERIAL | 2016-01-14 |
20160008408 | METHOD FOR PRODUCING HUMAN CORNEAL EPITHELIUM SHEET | 2016-01-14 |
20160008409 | SUPERCRITICAL CARBON DIOXIDE TISSUE PROCESSING METHODS | 2016-01-14 |
20160008410 | MICRONIZED WHARTON'S JELLY | 2016-01-14 |
20160008411 | BACTERIAL STRAINS HAVING AN OUTSTANDING ABILITY TO PRODUCE MENAQUINONE | 2016-01-14 |
20160008412 | PROBIOTIC BACTERIA FOR THE TOPICAL TREATMENT OF SKIN DISORDERS | 2016-01-14 |
20160008413 | TROPISM MODIFIED CANCER TERMINATOR VIRUS (AD.5/3 CTV;AD.5/3-CTV-M7) | 2016-01-14 |
20160008414 | PHARMACEUTICAL COMPOSITION CONTAINING SCEPTRIDIUM JAPONICUM EXTRACT FOR PREVENTING OR TREATING STROKE OR DEGENERATIVE BRAIN DISEASES | 2016-01-14 |
20160008415 | STABILIZED CREAM FORMULATIONS COMPRISING SANDALWOOD OIL | 2016-01-14 |
20160008416 | FORMULATIONS FOR PREVENTING AND TREATING DECREASING PLATELET CELL COUNTS | 2016-01-14 |
20160008417 | Plant and Animal Extracts and Related Methods | 2016-01-14 |
20160008418 | METHOD FOR MANUFACTURING WATER-SOLUBLE MEDICAL AMBER CRYSTALS | 2016-01-14 |
20160008419 | Methods and Compositions for the Prevention and Treatment of Parasitic Disease | 2016-01-14 |
20160008420 | Treatment Of HIV-1 Infection And AIDS | 2016-01-14 |
20160008421 | METHOD OF ALTERING VASCULAR PERMEABILITY AND USES THEREOF | 2016-01-14 |
20160008422 | COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF | 2016-01-14 |
20160008423 | Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans | 2016-01-14 |
20160008424 | APOE PEPTIDE DIMERS AND USES THEREOF | 2016-01-14 |
20160008425 | THERAPEUTIC AGENT FOR AMNIOTIC FLUID EMBOLISM | 2016-01-14 |
20160008426 | NOVEL STIP1 POLYPEPTIDES AND USES THEREOF | 2016-01-14 |
20160008427 | AFFINITY MATURED CRIg VARIANTS | 2016-01-14 |
20160008428 | COMPOSITIONS AND METHODS FOR ENHANCING CARDIAC FUNCTION | 2016-01-14 |
20160008429 | Methods for Achieving Therapeutically Effective Doses of anti-CD47 Agents | 2016-01-14 |
20160008431 | Tumor Therapy With Antitumor Agents In Combination With Sindbis Virus-Based Vectors | 2016-01-14 |
20160008432 | NEUREGULIN BASED METHODS FOR TREATING HEART FAILURE | 2016-01-14 |
20160008433 | PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE | 2016-01-14 |
20160008434 | STEM CELL FOR THERAPEUTIC USE WHICH IS DERIVED FROM HUMAN MONOCYTE, AND METHOD FOR INDUCING SAME | 2016-01-14 |